In the first study, microarray analysis of purified total CD8+ T cells from patients with active disease revealed that two distinct CD8+ expression signatures may serve to predict the clinical course of AAV and other autoimmune diseases such as SLE. The gene discussed is CD8A; the disease is systemic lupus erythematosus.